Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 338,341 | 297,304 | 264,192 | 242,077 | 334,605 |
| Marketable Securities | 1,901,830 | 1,992,676 | 1,880,960 | 2,055,579 | 2,148,671 |
| Receivables | 24,608 | 52,580 | 39,707 | 92,188 | 17,928 |
| Inventories | 10,470 | 8,481 | 11,502 | 12,512 | 28,452 |
| Other current assets | 243,744 | 226,109 | 222,571 | 217,934 | 184,194 |
| TOTAL | $2,518,993 | $2,577,150 | $2,418,932 | $2,620,290 | $2,713,850 |
| Non-Current Assets | |||||
| PPE Net | 106,117 | 111,951 | 102,925 | 94,251 | 82,502 |
| Other Non-Current Assets | 407,981 | 296,032 | 291,091 | 289,134 | 284,747 |
| TOTAL | $514,098 | $407,983 | $394,016 | $383,385 | $367,249 |
| Total Assets | $3,033,091 | $2,985,133 | $2,812,948 | $3,003,675 | $3,081,099 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 44,467 |
| Accounts payable and accrued liabilities | 14,326 | 22,800 | 17,456 | 42,964 | 9,052 |
| Accrued Expenses | 156,329 | 145,521 | 129,310 | 178,052 | 164,954 |
| Other current liabilities | 24,803 | 22,806 | 22,304 | 9,279 | 10,034 |
| TOTAL | $903,456 | $897,236 | $250,293 | $309,318 | $304,566 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 59,074 | N/A | N/A | N/A |
| Deferred Revenues | 76,986 | 75,910 | 81,097 | 78,989 | 76,018 |
| Other Non-Current Liabilities | 1,403,762 | 1,272,004 | 1,946,251 | 1,949,502 | 1,940,289 |
| TOTAL | $1,511,668 | $1,456,173 | $2,086,929 | $2,106,006 | $2,114,065 |
| Total Liabilities | $2,415,124 | $2,353,409 | $2,337,222 | $2,415,324 | $2,418,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 161,974 | 159,391 | 159,159 | 158,965 | 157,897 |
| Common Shares | 161 | 159 | 159 | 158 | 158 |
| Retained earnings | -2,401,801 | -2,273,195 | -2,396,746 | -2,249,808 | -2,145,459 |
| Other shareholders' equity | -25,978 | -27,987 | -28,949 | -30,811 | -24,173 |
| TOTAL | $617,967 | $631,724 | $475,726 | $588,351 | $662,468 |
| Total Liabilities And Equity | $3,033,091 | $2,985,133 | $2,812,948 | $3,003,675 | $3,081,099 |